Literature DB >> 28663397

Primary hip and knee arthroplasty in a temporary operating theatre is associated with a significant increase in deep periprosthetic infection.

B V Bloch1, A Shah1, S E Snape1, T C J Boswell1, P J James1.   

Abstract

AIMS: Infection following total hip or knee arthroplasty is a serious complication. We noted an increase in post-operative infection in cases carried out in temporary operating theatres. We therefore compared those cases performed in standard and temporary operating theatres and examined the deep periprosthetic infection rates. PATIENTS AND METHODS: A total of 1223 primary hip and knee arthroplasties were performed between August 2012 and June 2013. A total of 539 (44%) were performed in temporary theatres. The two groups were matched for age, gender, body mass index and American Society of Anesthesiologists grade.
RESULTS: The deep infection rate for standard operating theatres was 0 of 684 (0%); for temporary theatres it was eight of 539 (1.5%) (p = 0.001).
CONCLUSION: Use of a temporary operating theatre for primary hip and knee arthroplasty was associated with an unacceptable increase in deep infection. We do not advocate the use of these theatres for primary joint arthroplasty. Cite this article: Bone Joint J 2017;99-B:917-20. ©2017 The British Editorial Society of Bone & Joint Surgery.

Entities:  

Keywords:  Arthroplasty; Hip; Infection; Knee

Mesh:

Year:  2017        PMID: 28663397     DOI: 10.1302/0301-620X.99B7.BJJ-2016-1293.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  2 in total

1.  Intestinal methicillin-resistant Staphylococcus aureus causes prosthetic infection via 'Trojan Horse' mechanism: Evidence from a rat model.

Authors:  Hongyi Zhu; Hanqiang Jin; Changqing Zhang; Ting Yuan
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

2.  Gut permeability may be associated with periprosthetic joint infection after total hip and knee arthroplasty.

Authors:  Emanuele Chisari; Jeongeun Cho; Marjan Wouthuyzen-Bakker; Javad Parvizi
Journal:  Sci Rep       Date:  2022-09-05       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.